Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 15/161,840, filed May 23, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,238,643 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation In force · High confidence UsedRemaining | PureTech Health LLC | In force | High confidence | ||
| US 10,265,311 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation In force · Medium confidence | PureTech Health LLC | In force | Medium confidence | ||
| US 10,369,143 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation In force · High confidence | PureTech Health LLC | In force | High confidence | ||
| US 10,369,144 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation In force · High confidence | PureTech Health LLC | In force | High confidence | ||
| US 10,695,339 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation In force · High confidence | PureTech Health LLC | In force | High confidence | ||
| Application 16/880,634 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation Abandoned Abandoned Nov 8, 2023 | PureTech Health LLC | Abandoned | Abandoned Nov 8, 2023 | ||
| Application 18/461,741 | Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation Pending Not granted | PureTech Health LLC | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by PureTech Health LLC.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.